Doiron RC, Nickel JC, Kamdar S. The sublingual vaccine MV140 is dominant over prophylactic antibiotics for the prevention of recurrent, uncomplicated urinary tract infections in adult women: A cost-utility analysis. CUAJ [Internet]. 2026 Jan. 23 [cited 2026 May 20];20(5):E154-62. Available from: https://cuaj.ca/index.php/journal/article/view/9237